Skip to Content

Octreotide Injection

Last Updated: August 8, 2018
Status: Current

Products Affected - Description
    • Sandostatin injection, Novartis, 1000 mcg/mL, 5 mL vial, 1 count, NDC 00078-0184-25
    • Sandostatin injection, Novartis, 200 mcg/mL, 5 mL vial, 1 count, NDC 00078-0183-25
    • Octreotide Acetate injection, Fresenius Kabi, 50 mcg/mL, 1 mL vial, 10 count, NDC 63323-0365-01
    • Octreotide Acetate injection, Hikma, 1,000 mcg/mL, 5 mL multiple dose vial, 1 count, NDC 00641-6178-10
    • Octreotide Acetate injection, Hikma, 100 mcg/mL, 1 mL vial, 10 count, NDC 00641-6175-10
    • Octreotide Acetate injection, Hikma, 200 mcg/mL, 5 mL multiple dose vial, 1 count, NDC 00641-6177-10
    • Octreotide Acetate injection, Hikma, 50 mcg/mL, 1 mL vial, 10 count, NDC 00641-6174-10
    • Octreotide Acetate injection, Hikma, 500 mcg/mL, 1 mL vial, 10 count, NDC 00641-6176-10
    • Octreotide Acetate injection, Sagent, 500 mcg/mL, 1 mL vial, 10 count, NDC 25021-0453-01
    • Octreotide Acetate injection, Sun Pharma, 100 mcg/mL, 1 mL ampule, 10 count, NDC 62756-0349-44
    • Octreotide Acetate injection, Sun Pharma, 1000 mcg/mL, 5 mL vial, 1 count, NDC 62756-0352-40
    • Octreotide Acetate injection, Sun Pharma, 200 mcg/mL, 5 mL vial, 1 count, NDC 62756-0350-40
    • Octreotide Acetate injection, Sun Pharma, 50 mcg/mL, 1 mL ampule, 10 count, NDC 62756-0348-44
    • Octreotide Acetate injection, Sun Pharma, 500 mcg/mL, 1 mL ampule, 10 count, NDC 62756-0351-44
Reason for the Shortage
    • Fresenius Kabi has octreotide available.
    • Mylan Institutional has octreotide available.
    • Sagent has octreotide on shortage due to manufacturing delays.
    • Sun Pharma did not provide a reason for the shortage.
    • Teva has octreotide available.
    • Novartis has Sandostatin available. The 200 mcg/mL 5 mL vials were discontinued in early-2018.
    • Hikma did not provide a reason for the shortage.
Available Products
    • Sandostatin injection, Novartis, 100 mcg/mL, 1 mL ampule, 10 count, NDC 00078-0181-01
    • Sandostatin injection, Novartis, 50 mcg/mL, 1 mL ampule, 10 count, NDC 00078-0180-01
    • Sandostatin injection, Novartis, 500 mcg/mL, 1 mL ampule, 10 count, NDC 00078-0182-01
    • Octreotide Acetate injection, Fresenius Kabi, 100 mcg/mL, 1 mL vial, 10 count, NDC 63323-0376-01
    • Octreotide Acetate injection, Fresenius Kabi, 1000 mcg/mL, 5 mL vial, 1 count, NDC 63323-0379-05
    • Octreotide Acetate injection, Fresenius Kabi, 200 mcg/mL, 5 mL vial, 1 count, NDC 63323-0378-05
    • Octreotide Acetate injection, Fresenius Kabi, 500 mcg/mL, 1 mL vial, 10 count, NDC 63323-0377-01
    • Octreotide Acetate injection, Mylan Institutional, 100 mcg/mL, 1 mL syringe, 10 count, NDC 67457-0245-01
    • Octreotide Acetate injection, Mylan Institutional, 50 mcg/mL, 1 mL syringe, 10 count, NDC 67457-0239-01
    • Octreotide Acetate injection, Mylan Institutional, 500 mcg/mL, 1 mL syringe, 10 count, NDC 67457-0246-01
    • Octreotide Acetate injection, Sagent, 100 mcg/mL, 1 mL vial, 10 count, NDC 25021-0452-01
    • Octreotide Acetate injection, Sagent, 1000 mcg/mL, 5 mL vial, 1 count, NDC 25021-0455-05
    • Octreotide Acetate injection, Sagent, 200 mcg/mL, 5 mL vial, 1 count, NDC 25021-0454-05
    • Octreotide Acetate injection, Sagent, 50 mcg/mL, 1 mL vial, 10 count, NDC 25021-0451-01
    • Octreotide Acetate injection, Teva, 100 mcg/mL, 1 mL vial, 25 count, NDC 00703-3311-04
    • Octreotide Acetate injection, Teva, 1000 mcg/mL, 5 mL vial, 1 count, NDC 00703-3343-01
    • Octreotide Acetate injection, Teva, 200 mcg/mL, 5 mL vial, 1 count, NDC 00703-3333-01
    • Octreotide Acetate injection, Teva, 50 mcg/mL, 1 mL vial, 25 count, NDC 00703-3301-04
    • Octreotide Acetate injection, Teva, 500 mcg/mL, 1 mL vial, 25 count, NDC 00703-3321-04

Estimated Resupply Dates

    • Fresenius Kabi has octreotide 50 mcg/mL 1 mL vials on back order and the company cannot estimate a release date.
    • Hikma has all presentations available but with short expiration dating.
    • Sagent has 500 mcg/mL 1 mL vials on allocation.
    • Sun Pharma has all octreotide presentations on back order and the company cannot estimate a release date.

Updated

Updated August 8, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 16, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide